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840 Adult Congenital Heart Disease
Tuesday, March 09, 2004, 10:30 a.m.-Noon
Morial Convention Center, Room 260
10:30 a.m.
840-1 Myocardial Fibrosis Patterns Correlate With Adverse 
Right Ventricular Morphology and Function in Patients 
With Repaired Conotruncal Heart Defects
Anne Marie Valente, Salim F. Idriss, Peter Cawley, John Heitner, Igor Klem, Jospeh Kay, 
Ann Marie Nawrocki, Michele Parker, J. Rene' Herlong, Raymond Kim, Duke University 
Medical Center, Durham, NC
Background: Repair of tetralogy of Fallot (TOF) and transposition of the great arteries
(TGA), the most common conotruncal congenital heart defects, often results in right ven-
tricular (RV) volume and/or pressure overload. RV failure often ensues over time. Myo-
cardial fibrosis may be an important correlate of RV dysfunction and adverse RV
remodeling. Delayed contrast enhancement cardiac MRI (DEMRI) is known to be a sen-
sitive technique for determining the presence, location and extent of myocardial fibrosis
in vivo. The purpose of this study was to correlate the presence, location and extent of
myocardial fibrosis on DEMRI with RV volumes and function, as well as QRS duration in
patients with repaired TOF or TGA.
Methods: Twenty seven patients with TOF or TGA were prospectively identified and
underwent cine and DEMRI. Measurements of RV morphology and function were
assessed on the cine images, and the extent of hyperenhancement (HE) was assessed
on delayed enhancement images. QRS duration was measured from the standard elec-
trocardiogram.
Results: All patients, regardless of RV size and function, had evidence of some myocar-
dial fibrosis as determined by the presence of HE. However, there was a predilection of
myocardial fibrosis for specific locations. In particular, the junction of the RV freewall with
the interventricular septum was commonly involved (100% at the inferior septal junction,
56% at the anterior septal junction). Six patients (22%) had direct involvement of the right
ventricular free wall. The extent of HE correlated with RVEDV and RVESV (p<0.01). In
addition, QRS duration correlated with RVEDV, RVESV, and RVEF (p<0.05, all).
Conclusion: Patients with repaired conotruncal congenital heart defects such as TOF and
TGA have areas of myocardial fibrosis that are located remote from sites of direct surgi-
cal intervention. The concentration of myocardial fibrosis in these unexpected locations
remains to be explained. The extent of fibrosis in these patients and QRS duration corre-
lates with adverse right ventricular morphology and function. Future investigations of the
relationship between right ventricular fibrosis characteristics and outcomes in this patient
population are necessary.
10:45 a.m.
840-2 Mismatch of the Coronary Circulation: Impact on the 
Systemic Right Ventricle
Michael Hauser, Heiko Stern, Frank Bengel, Sohrab Fratz, Alfred Hager, Stefan Nekolla, 
Harald Kaemmerer, Markus Schwaiger, John Hess, German Heart Centre Munich, 
Munich, Germany, Nuklearmedizinische Klinik der TU-Munich, Munich, Germany
Background: Ventricular dysfunction of the systemic right ventricle (RV) is evident in at
least 10% of patients at 10 years and may be caused by a mismatch between O2
demand and supply.
Methods: We investigated 20 patients (22.7 SD 4.9 yrs) with TGA after atrial repair (ASO)
and 15 patients (30.6 SD 16.4 yrs) with unoperated congenitally corrected transposition
(CCTGA); 11 normals (26.2 SD 5.2 yrs) served as controls for the myocardial blood flow
(MBF). All patients had spiroergometry, MRI and positron emission tomography (NH3,
rest / Adenosine); all ASO patients additionally had cardiac catherization.
Results: MBFrest did not differ between patients with ASO, CCTGA and controls, whilst
MBFstress (ASO 167 SD 46* vs. CCTGA 198 SD 38* vs. controls 310 SD 74 ml/100g/
min.; p<0.001) and coronary flow reserve (ASO 2.3 SD 0.4* vs. CCTGA 2.6 SD 0.6* vs.
controls 4.1 SD 0.7; p<0.001) were significantly reduced; angiography did not show any
stenosis of the coronary arteries, suggesting microvascular disease. In both patient
groups a negativ correlation between ventricular mass and MBFrest could be calculated.
In CCTGA there additionally was a significant correlation between CFR and the increase
of the systolic function after dobutamine administration on MRI (r=0.71; p<0.01), BNP-
levels (r=0.69; p<0.01) and VO2 max. (r=0.62; p<0.01). In patients with ASO, CFR is not
significantly correlated with ventricular function, BNP and VO2 max, suggesting a multi-
factorial process (attenuated atrial compliance with reduced preload).
Conclusion: The intrinsic geometry of the systemic RV and the process of remodelling
(myocyte hypertrophy and disarray, interstitial fibrosis, inadequate capillary growth, thick-
ening of the media of intramural coronary arteries) may contribute to limited nutritional
support with ventricular deterioration and electrical instability; the mismatch between O2
demand and supply is an important risk factor for the long-term prognosis of patients with
morphologic right ventricle; in patients with TGA after atrial repair it is at least one impor-
tant cofactor causing ventricular deterioration.
11:00 a.m.
840-3 Bicuspid Aortic Valve in Athletes: An Underestimated 
Problem?
Giorgio Galanti, Marta Rizzo, Paolo Manetti, Valentina Di Tante, Alfredo Guerrisi, Maria 
Concetta Robertina Vono, Jacopo Giuliattini, Loira Toncelli, University of Florence, 
Florence, Italy
Background. Bicuspid aortic valve (BAV) is likely to be a common cardiac disease in ath-
letes, however to date, limited data are available. The great concern of sports medicine
physicians for BAV is related to the valvular and vascular complications characterizing
the natural history of disease which are likely to be accelerated or worsen by athletic
training.
Object. The present investigation was designed to evaluate the prevalence of bicuspid
aortic valve (BAV) among a large group of unselected, competitive asymptomatic ath-
letes and the prevalence and the extent of associated complications, compared to those
reported in community-based studies.
Method. In a 3-years period, 2273 (788 F and 1485 M) consecutive competitive athletes
aged 8 to 60 years (average: 31±11.3 years), representing 16 different sports were eval-
uated by Echocardiography (Echo). Echo measurements included aortic root dimensions
at four levels: aortic annulus, sinuses of Valsalva, sinotubular junction and proximal
ascending aorta.
Results. BAV was diagnosed in 58 athletes, corresponding to a prevalence of 2,55%, sig-
nificantly greater than prevalence reported in population-based studies.
BAV was normally functioning in only 9 athletes. Aortic regurgitation was detected in the
other 49 athletes. It was mild in 14 athletes, moderate in 27 and moderate-to-severe in 8.
A moderate aortic stenosis was documented in two athletes.
Aortic root dimensions at all the measured levels were significantly larger in athletes with
BAV than in athletes with tricuspid aortic valve. Aortic dilatation was not associated with
age, body surface area, presence and extent of aortic regurgitation, nor with the years of
training.
15 BAV athletes were disqualified from competition because severe aortic regurgitation
associated to left ventricular dilatation or aortic dilatation, independently from valvular
functioning.
Conclusions. The results of this investigation highlights on the high prevalence of BAV
and its complications in athletic population and suggest the importance of strongly sup-
port the implementation of pre-participation screening with echocardiography
11:15 a.m.
840-4 Failing Fontan Circulation Necessitating 
Transplantation: A Clinicopathologic Correlation
Fotios A. Mitropoulos, Hillel Laks, Jacques Neelankavil, Juan Alejos, John S. Child, Vivek 
Allada, Stacey Drant, Jon Kobashigawa, Jonah Odim, Michael Fishbein, Mark Plunkett, 
UCLA Medical Center, Los Angeles, CA, Mattel's Childrens Hospital, Los Angeles, CA
Background: Some patients with Fontan palliation for univentricular congenital heart dis-
ease will eventually fail and require orthotopic heart transplantation (OHT).This particular
mode of cardiovascular failure has been investigated in the past focusing primarily on the
Fontan pathway and its obstruction. We sought to describe and define the clinical-patho-
logic events that occur in the univentricular heart.
Methods: We retrospectively analyzed the data from 31 patients (19 males and 12
females) with Fontan physiology who underwent OHT at a mean age of 17 years (range,
7-48) with special emphasis on the pathological changes of the explanted heart.
Results: All 31 patients were in NYHA class III or IV, and 14/31 required pacemaker ther-
apy for arrhythmias (10/14 atrial dysrhythmias, 1/14 junctional bradycardia, 2/14 ventricu-
lar tachycardia, and 1/14 sick sinus syndrome). The mean Fontan pressure was 24.5
mmHg (range, 7-26). Echo data available in 24/31 revealed a mean ejection fraction of
23% (range, 10-45). In 19/24 patients atrioventricular valve regurgitation was moderate to
severe in 11/19 and mild in 7/19. Mean heart weight was 371g (range, 120-880). The
mean percentage of hypertrophy based on the patient’s height was 156% (range, 60-
436). Microscopically, fibrosis was present in all but one explanted heart: 10/31 had inter-
stitial fibrosis, 13/31 had replacement fibrosis, 7/31 had both, and 1/31 had myocardial
fibroelastosis. The mean free ventricular wall thickness was 1.75 cm (range, 1.0-3.2).
Conclusion: Failing univentricular hearts with Fontan circulation demonstrate similar clini-
copathologic changes to the biventricular hearts that fail. These findings argue for routine
anticongestive medical therapy post-Fontan to delay and/or prevent adverse remodeling
and failure of the univentricular heart. A prospective trial is proposed to address this
issue.
11:30 a.m.
840-5 Should Mechanical Valves Be Used in the Pulmonary 
Position
John M. Stulak, Heidi M. Connolly, Francisco J. Puga, Joseph A. Dearani, Carole A. 
Warnes, Hartzell V. Schaff, Mayo Clinic, Rochester, MN
Objectives: Bioprostheses are the most commonly used valve substitutes in the pulmo-
nary position, but most require late re-replacement. Mechanical valves may have better
durability, but there are conflicting reports regarding late outcome of these prostheses for
pulmonary valve replacement (PVR).
Methods: We reviewed 10 patients (pts) (27 +/- 12 years (yrs)) who underwent mechani-
cal PVR between January 1969 and June 2002. Diagnoses included carcinoid heart dis-
ease (n=4), double outlet right ventricle (n=2), pulmonary stenosis/atresia (n=2),
transposition of the great arteries (n=1), and truncus arteriosus (n=1). Eight had PVR at
our institution and 2 pts underwent PVR elsewhere.
